Global Non-invasive Parenteral Screening Market Size, Status and Forecast 2020-2026

Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.
Market Analysis and Insights: Global Non-invasive Parenteral Screening Market
In 2019, the global Non-invasive Parenteral Screening market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Non-invasive Parenteral Screening Scope and Market Size
Non-invasive Parenteral Screening market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-invasive Parenteral Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Non-invasive Parenteral Screening market is segmented into Instruments, Consumables, etc.
Segment by Application, the Non-invasive Parenteral Screening market is segmented into Diagnostic Laboratories, Hospitals, etc.
Regional and Country-level Analysis
The Non-invasive Parenteral Screening market is analysed and market size information is provided by regions (countries).
The key regions covered in the Non-invasive Parenteral Screening market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Non-invasive Parenteral Screening Market Share Analysis
Non-invasive Parenteral Screening market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Non-invasive Parenteral Screening business, the date to enter into the Non-invasive Parenteral Screening market, Non-invasive Parenteral Screening product introduction, recent developments, etc.
The major vendors include GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen, Agilent Technologies, BGI Group, etc.

This report focuses on the global Non-invasive Parenteral Screening status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-invasive Parenteral Screening development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

GE Healthcare
Philips
Illumina
Thermo Fisher Scientific
Roche
PacBio
Perkinelmer
Qiagen
Agilent Technologies
BGI Group

Market segment by Type, the product can be split into

Instruments
Consumables

Market segment by Application, split into

Diagnostic Laboratories
Hospitals

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Non-invasive Parenteral Screening status, future forecast, growth opportunity, key market and key players.
To present the Non-invasive Parenteral Screening development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Non-invasive Parenteral Screening are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.